GIP Receptor Agonism: Unlocking New Potential for Diabetes and Obesity Treatment

Clinical Potential of GIP in Type 2 Diabetes and Obesity. Authors: Nauck M, Gribble F, Reimann F, D'Alessio DA, Campbell JE Journal: Diabetes care (2026) DOI: 10.2337/dci25-0141 Incretin-based pharmacology has revolutionized the medical t…